Table 3.
|
Clinical group |
Genotype |
Pre-S2 S tart codon |
Deletions |
|||||
---|---|---|---|---|---|---|---|---|---|
|
|
|
|
Region |
Nucleotides |
Amino acids |
Region and functions affected |
||
ID | Size | Position | Size | position | |||||
SDAC024 |
CR |
D |
ATG |
Pre-S2 |
21 |
35-55a |
7 |
16-22a |
|
SDAC048 |
CR |
D |
ATG |
Pre-S1 |
72 |
2998-3069 |
24 |
51-74 |
S promoter, Transactivator domain |
SDAC083 |
CR |
D |
ATG |
Pre-S2 |
21 |
35-55 |
7 |
16-22 |
|
SDAC097 |
CR |
D |
GTGb |
Pre-S 2 |
9 |
45- 53 |
3 |
19-21 |
|
SDAC098 |
CH |
D |
ATG |
Pre-S1 |
18 |
3129-3146 |
6 |
94-99 |
Hsc70 binding site, CCAAT binding factor (CBF) binding site, Cytosolic anchorage determinant (CAD) |
SDAC112 |
ASC |
D |
ATG |
Pre-S2 |
6 |
49-54 |
2 |
20-21 |
|
SDAC118 |
CR |
D |
ATG |
Pre-S2 |
54 |
4-57 |
18 |
5 to 22 |
pHSA binding site, Viral secretion |
SDAC107 |
CR |
D |
ATA |
- |
- |
- |
- |
- |
- |
SDAC090 |
CR |
D |
ATA |
- |
- |
- |
- |
- |
- |
SDAC058 |
CR |
E |
ATG |
Pre-S2 |
9 |
58-66c |
3 |
20-22c |
Transactivator domain |
SDAC059 |
HCC |
E |
GTG |
Pre-S2 |
12 |
52-63 |
4 |
18-21 |
Transactivator domain |
SDAC088 |
HCC |
E |
ATG |
Pre-S2 |
12 |
52-63 |
4 |
18-21 |
Transactivator domain |
SDAC095 |
HCC |
E |
ATG |
Pre-S2 |
15 |
52-66 |
5 |
18-22 |
Transactivator domain |
SDAC067 |
ASC |
E |
GTG |
- |
- |
- |
- |
- |
- |
SDAC113 | ASC | A | ACA | - | - | - | - | - | - |